Volume of distribution in steady state and Bioequivalence [Design Issues]

posted by javier – Spain, 2016-09-14 18:18 (3566 d 14:15 ago) – Posting: # 16637
Views: 7,477

Hi again!

After more time than I would have liked to see, Im coming back to the forum with one question about BE studies

I was reading an article about PK study single dose Healthy volunteers comparing the two drugs,and I was surprised by the Vdss as one pharmacokinetic parameter to match Bioequivalence

I thought Steady state is more appropriate for a multiple dose study, when you can observe the steady state equilibrium (after 3-5 half lives)

So if someone can enlighten about it, i would appreciate it very much

Kinds regards

Javier

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
136 visitors (0 registered, 136 guests [including 14 identified bots]).
Forum time: 08:34 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5